European Markets for Optical Coherence Tomography Catheters 2015 – MedCore

European Markets for Optical Coherence Tomography Catheters 2015 – MedCore


  • Year: 2015
  • Scope: 2011-2021
  • Region: Europe
  • Published Date: 12/01/2015
  • Pages: 56
  • Type: MedCore

Optical coherence tomography (OCT) is an imaging modality that can create extremely high resolution three-dimensional images of biological tissues and has proven to be very effective for interventional purposes. While OCT has been used for a number of years in other medical fields, such as in ophthalmology, it has only recently been applied to cardiology. In 2014, only a few OCT systems were approved by the FDA for use in cardiology. However, OCT systems were being used for producing high resolution images of arteries in a clinical setting since 2006 in Japan and Europe.

OCT delivers high resolution because it utilizes light, rather than sound or radio frequencies. In coronary applications, OCT involves directing an optical beam from a catheter extended into the artery of interest. This light penetrates with a depth of 1 mm to 2 mm into the tissue and a small portion of the light that reflects from the sub-surface features is collected. The majority of this collected light is not reflected, but scattered in a way that causes an effect similar to glare. However, the OCT technique can filter out this reflected light, allowing it to produce an image based only on the small proportion of the collected light that is reflected by the tissues.
Because OCT can only image tissues at a depth of a few millimeters, it must be performed endovascularly in cardiology applications. As a result, OCT is most often compared to another imaging technology, intravascular ultrasound (IVUS). Compared to IVUS, OCT produces much higher resolution images, but it cannot produce as broad an image of the cardiovascular system. The main drawback of first generation OCT systems compared to IVUS is the fact that blood flow through the artery must be stopped (for a short time) with a specialized catheter prior to OCT imaging. This is due to the fact that blood can attenuate the OCT optical beam. While this drawback existed in the majority of first generation OCT systems used in Europe and Japan, second generation systems operating on the concept of optical frequency domain imaging (OFDI) are expected to mitigate this problem. OFDI is capable of acquiring images at much higher frame rates than standard OCT, allowing for the imaging of coronary arteries following a brief flush of the artery with saline. Please note that OFDI is sometimes referred to as Fourier domain optical coherence tomography (FD-OCT).

The "European Markets for Interventional Cardiology Devices 2015 - MedSuite" includes analysis on the following companies currently active in this market:
Boston Scientific
Abbott Laboratories
St. Jude Medical
Volcano Therapeutics
B. Braun
Others include: Blue Medical, Bolton Medical, Cardiovascular Systems Inc, C.R. Bard, Elixir Medical Corp, Invatec

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.



Sign Up

Already have an account? Sign in